TAK Takeda Pharmaceutical Company Limited American Depositary Shares Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
20:33
Jul 05
Jul 05
Taiko Critical Minerals receives government offer of up to NZ$20 million in financial.
Taiko Critical Minerals receives government offer of up to NZ$20 million in financial assistance and is currently negotiating terms with officials.
00:10
Jul 02
Jul 02
Takeda and Insilico Medicine have entered into an AI drug discovery agreement valued at up.
Takeda and Insilico Medicine have entered into an AI drug discovery agreement valued at up to 600 million dollars according to the Wall Street Journal.
09:55
Jun 25
Jun 25
Takeda Pharmaceutical's newly appointed CEO states the company will return to growth in two.
Takeda Pharmaceutical's newly appointed CEO states the company will return to growth in two to three years as it prepares for upcoming product launches.
03:40
Jun 17
Jun 17
The author presents a factual analysis of M&A activity in the biotech sector since Covid.
The author presents a factual analysis of M&A activity in the biotech sector since Covid, noting that many large pharma companies have not yet engaged in significant deals, but does not express a personal position or forward-looking trade call.
LOW
12:26
Jun 05
Jun 05
Author provides a detailed valuation analysis for ABVX with a 105% premium price target.
Author provides a detailed valuation analysis for ABVX with a 105% premium price target of ~$218, implying a bullish acquisition thesis based on comps and peak sales multiples.
LOW
22:00
Feb 25
Feb 25
Takeda is consolidating on Salesforce for life sciences, moving away from Microsoft's Viva.
HIGH
About TAK Analyst Coverage
Buzzberg tracks TAK (Takeda Pharmaceutical Company Limited American Depositary Shares) across 4 sources. 0 bullish vs 0 bearish calls from 4 analysts. Sentiment: evenly split. 6 total trade ideas tracked. Latest voices: FirstSquawk, Bloomberg, seedy19tron.